CKPT Similar Chart Price Prediction
The price of CKPT is predicted to go up 0.49%, based on the high correlation periods with MCY. The similarity of these two price pattern on the periods is 91.85%.
CKPT
MCY
Up: 0.49%Similarity: 91.85%
CKPT Revenue Forecast
CKPT EPS Forecast
CKPT FAQs
What is bull’s view on CKPT?
What is bear's view on CKPT?
CKPT Analyst's Forecast
Jason Kolbert
D. Boral Capital
Strong Buy
2025-01-13
Price Target
$9
Upside
+200%
D. Boral Capital initiated coverage of Checkpoint Therapeutics with a Buy rating and $9 price target. The company's lead drug, Unloxcty, was approved in December and is a PD-L1 inhibitor that blocks the interaction between PD-L1 and PD-1, preventing immune evasion by tumors band is engineered with a functional Fc region that retains antibody-dependent cellular cytotoxicity, the analyst tells investors in a research note. The firm says this can enhance immune-mediated killing of cancer cells, which positions the drug to compete in the now competitive immune-oncology marketplace.
